CoChat

(1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections

Mikulska, M., Furfaro, E., Del Bono, V., Raiola, A. M., Di Grazia, C., Bacigalupo, A., Viscoli, C. · 2013 · Clinical Infectious Diseases
Cited by 46

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

To the Editor—A definitive diagnosis of invasive fungal infection (IFI) remains difficult in immunocompromised hosts. Thus, fungal markers such as galactomannan (GM) or (1-3)-β-D-glucan (BG) are useful for the diagnosis of probable IFI in high risk patients [1]. Detection of GM in cerebrospinal fluid (CSF) has been studied and is now considered diagnostic for central nervous system (CNS) aspergillosis in high-risk patients with a compatible neurological disease [1, 2]. Serum BG, major constituent of fungi other than the Mucorales, is being used for noninvasive diagnosis of fungal infection, and has been included as microbiological criterion for the diagnosis of probable IFI in the revised definitions of IFI of the European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) [1]. BG has been widely studied in serum, but only 1 animal study has analyzed its levels in CSF in a nonneutropenic rabbit model of experimental hematogenous Candida meningoencephalitis [3]. The aim of this study was to assess the utility of BG in CSF in patients with cerebral IFI, particularly aspergillosis. Five patients with CNS IFI, for whom CSF was available, were included in the study: 3 patients with probable CNS aspergillosis; 1 patient with proven cerebral histoplasmosis, and 1 with proven cryptococcal meningitis. Aspergillosis was classified according to 2008 EORTC/MSG criteria, with positive GM in CSF and compatible cerebral lesions in case of probable CNS aspergillosis [1]. CSF samples from 19 patients without IFI were included as controls. BG and GM testing were performed with Fungitell (Associates of Cape Cod, Inc, Falmouth, Massachusetts), and Platelia Aspergillus (Bio-Rad, Paris, France) assays, respectively, according to the manufacturers’ instructions. Values >80 pg/mL for BG and 0.5 optical density index for GM were considered positive. Clinical characteristics of patients with cerebral IFI are shown in Table 1. CSF was positive for BG in all 5 patients with CNS IFI, with a mean concentration of 352 pg/mL and a median concentration of 331 pg/mL (range, 103–523 pg/mL); 18 of 19 control patients had negative results for BG with a mean concentration of 37.1 pg/mL and a median concentration of 32 pg/mL (range, 7–115 pg/mL). The test showed a high specificity, and the only 1 positive BG in a control patient had a low concentration (115 pg/mL). Clinical Characteristics of Patients With Cerebral Invasive Fungal Infections Abbreviations: CSF, cerebrospinal fluid; GM, galactomannan; HSCT, hematopoietic stem cell transplant; MMF, mycophenolate mofetil; ODI, optical density index; SLE, systemic lupus erythematosus. a On the day of lumbar puncture, except for patients 1 and 3, in whom serum sample was drawn 2 days before lumbar puncture. Clinical Characteristics of Patients With Cerebral Invasive Fungal Infections Abbreviations: CSF, cerebrospinal fluid; GM, galactomannan; HSCT, hematopoietic stem cell transplant; MMF, mycophenolate mofetil; ODI, optical density index; SLE, systemic lupus erythematosus. a On the day of lumbar puncture, except for patients 1 and 3, in whom serum sample was drawn 2 days before lumbar puncture. Cryptococcus has been reported to release low levels of BG [4], even 10 times lower than Candida [5]. Whereas 2 studies found BG to be consistently negative in patients with cryptococcosis (5 and 3 cases, respectively) [6, 7], others reported serum BG positivity in some or all cases of cryptococcosis (3 of 12, 5 of 6, and 3 of 3 [8–10]). In conclusion, BG is useful for the diagnosis of different cerebral IFIs, including aspergillosis, histoplasmosis, and probably some cases of cryptococcosis. Our results suggest that a positive BG in CSF might be included in the EORTC/MSG microbiological criteria for the diagnosis of CNS IFI in high-risk patients. Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cit073

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 46

Metadata

Authors
Mikulska, M., Furfaro, E., Del Bono, V., Raiola, A. M., Di Grazia, C., Bacigalupo, A., & Viscoli, C.
Venue
Clinical Infectious Diseases
Published
2013-02-07
Volume
56
Issue
10
Pages
1511-1512
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2099345757
Cited by
46
References
1
FWCI
6.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: (1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections. https://app.cochat.ai/papers/10.1093/cid/cit073
The paper
Mikulska, M., Furfaro, E., Del Bono, V., Raiola, A. M., Di Grazia, C., Bacigalupo, A., & Viscoli, C. (2013). (1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit073

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.